{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T06:10:50Z","timestamp":1650089450052},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,8,27]],"date-time":"2014-08-27T00:00:00Z","timestamp":1409097600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1007\/s00213-014-3722-z","type":"journal-article","created":{"date-parts":[[2014,8,26]],"date-time":"2014-08-26T02:46:30Z","timestamp":1409021190000},"page":"897-905","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A longitudinal study of self-reported psychopathology in early ecstasy and amphetamine users"],"prefix":"10.1007","volume":"232","author":[{"given":"Daniel","family":"Wagner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Koester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Euphrosyne","family":"Gouzoulis-Mayfrank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Hellmich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joerg","family":"Daumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,8,27]]},"reference":[{"key":"3722_CR1","first-page":"301","volume":"31","author":"AM Barr","year":"2006","unstructured":"Barr AM, Panenka WJ, MacEwan GW, Thornton AE, Lang DJ, Honer WG, Lecomte T (2006) The need for speed: an update on methamphetamine addiction. J Psychiatry Neurosci 31:301\u2013313","journal-title":"J Psychiatry Neurosci"},{"key":"3722_CR2","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00213-010-1805-z","volume":"209","author":"B Becker","year":"2010","unstructured":"Becker B, Wagner D, Gouzoulis-Mayfrank E, Spuentrup E, Daumann J (2010) Altered parahippocampal functioning in cannabis users is related to the frequency of use. Psychopharmacology (Berl) 209:361\u2013374","journal-title":"Psychopharmacology (Berl)"},{"key":"3722_CR3","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/0269881108097631","volume":"24","author":"G Bedi","year":"2010","unstructured":"Bedi G, Van Dam NT, Redman J (2010) Ecstasy (MDMA) and high prevalence psychiatric symptomatology: somatic anxiety symptoms are associated with polydrug, not ecstasy, use. J Psychopharmacol 24:233\u2013240","journal-title":"J Psychopharmacol"},{"key":"3722_CR4","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1192\/bjp.111.477.701","volume":"111","author":"DS Bell","year":"1965","unstructured":"Bell DS (1965) Comparison of amphetamine psychosis and schizophrenia. Br J Psychiatry 111:701\u2013707","journal-title":"Br J Psychiatry"},{"key":"3722_CR5","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1136\/bmj.1.5018.582","volume":"1","author":"PH Connell","year":"1957","unstructured":"Connell PH (1957) Amphetamine psychosis. Br Med J 1:582","journal-title":"Br Med J"},{"key":"3722_CR6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0376-8716(00)00164-2","volume":"62","author":"AL Copeland","year":"2001","unstructured":"Copeland AL, Sorensen JL (2001) Differences between methamphetamine users and cocaine users in treatment. Drug Alcohol Depend 62:91\u201395","journal-title":"Drug Alcohol Depend"},{"key":"3722_CR7","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/09595230801923702","volume":"27","author":"S Darke","year":"2008","unstructured":"Darke S, Kaye S, McKetin R, Duflou J (2008) Major physical and psychological harms of methamphetamine use. Drug Alcohol Rev 27:253\u2013262","journal-title":"Drug Alcohol Rev"},{"key":"3722_CR8","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s00213-003-1719-0","volume":"173","author":"J Daumann","year":"2004","unstructured":"Daumann J, Hensen G, Thimm B, Rezk M, Till B, Gouzoulis-Mayfrank E (2004) Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional\/longitudinal investigation. Psychopharmacology (Berl) 173:398\u2013404","journal-title":"Psychopharmacology (Berl)"},{"key":"3722_CR9","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/hup.342","volume":"16","author":"J Daumann","year":"2001","unstructured":"Daumann J, Pelz S, Becker S, Tuchtenhagen F, Gouzoulis-Mayfrank E (2001) Psychological profile of abstinent recreational Ecstasy (MDMA) users and significance of concomitant cannabis use. Hum Psychopharmacol Clin 16:627\u2013633","journal-title":"Hum Psychopharmacol Clin"},{"key":"3722_CR10","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1177\/0269881106063275","volume":"20","author":"MM Win de","year":"2006","unstructured":"de Win MM, Schilt T, Reneman L, Vervaeke H, Jager G, Dijkink S, Booij J, van den Brink W (2006) Ecstasy use and self-reported depression, impulsivity, and sensation seeking: a prospective cohort study. J Psychopharmacol 20:226\u2013235","journal-title":"J Psychopharmacol"},{"key":"3722_CR11","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1017\/S0033291707009956","volume":"37","author":"L Degenhardt","year":"2007","unstructured":"Degenhardt L, Tennant C, Gilmour S, Schofield D, Nash L, Hall W, McKay D (2007) The temporal dynamics of relationships between cannabis, psychosis and depression among young adults with psychotic disorders: findings from a 10-month prospective study. Psychol Med 37:927\u2013934","journal-title":"Psychol Med"},{"key":"3722_CR12","doi-asserted-by":"crossref","unstructured":"Derogatis LR (1977) Symptom check list-90 revised. Administration scoring and procedures manual. Clinical Psychometrics Unit, Johns Hopkins University, Baltimore","DOI":"10.1037\/t01210-000"},{"issue":"Suppl","key":"3722_CR13","first-page":"45","volume":"14","author":"AD Domar","year":"1993","unstructured":"Domar AD, Zuttermeister PC, Friedman R (1993) The psychological impact of infertility: a comparison with patients with other medical conditions. J Psychosom Obstet Gynaecol 14(Suppl):45\u201352","journal-title":"J Psychosom Obstet Gynaecol"},{"key":"3722_CR14","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00005053-196704000-00005","volume":"144","author":"EH Ellinwoo","year":"1967","unstructured":"Ellinwoo EH (1967) Amphetamine psychosis .I. Description of individuals and process. J Nerv Ment Dis 144:273","journal-title":"J Nerv Ment Dis"},{"key":"3722_CR15","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1037\/1040-3590.18.4.359","volume":"18","author":"R Elliott","year":"2006","unstructured":"Elliott R, Fox CM, Beltyukova SA, Stone GE, Gunderson J, Zhang X (2006) Deconstructing therapy outcome measurement with Rasch analysis of a measure of general clinical distress: the symptom checklist-90-revised. Psychol Assess 18:359\u2013372","journal-title":"Psychol Assess"},{"key":"3722_CR16","unstructured":"EMCDDA (2012) Annual report 2012: the state of the drugs problem in Europe. Publications Office of the European Union, Luxembourg"},{"key":"3722_CR17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/0269881107078293","volume":"22","author":"RS Falck","year":"2008","unstructured":"Falck RS, Wang J, Carlson RG (2008) Depressive symptomatology in young adults with a history of MDMA use: a longitudinal analysis. J Psychopharmacol 22:47\u201354","journal-title":"J Psychopharmacol"},{"key":"3722_CR18","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1080\/10826080701212428","volume":"42","author":"I Giraudon","year":"2007","unstructured":"Giraudon I, Bello PY (2007) Monitoring ecstasy content in France: results from the national surveillance system 1999\u20132004. Subst Use Misuse 42:1567\u20131578","journal-title":"Subst Use Misuse"},{"key":"3722_CR19","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1465-3362.2009.00081.x","volume":"29","author":"S Glasner-Edwards","year":"2010","unstructured":"Glasner-Edwards S, Mooney LJ, Marinelli-Casey P, Hillhouse M, Ang A, Rawson RA (2010) Psychopathology in methamphetamine-dependent adults 3 years after treatment. Drug Alcohol Rev 29:12\u201320","journal-title":"Drug Alcohol Rev"},{"key":"3722_CR20","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1177\/0269881106059939","volume":"20","author":"E Gouzoulis-Mayfrank","year":"2006","unstructured":"Gouzoulis-Mayfrank E, Daumann J (2006a) The confounding problem of polydrug use in recreational ecstasy\/MDMA users: a brief overview. J Psychopharmacol 20:188\u2013193","journal-title":"J Psychopharmacol"},{"key":"3722_CR21","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1360-0443.2006.01314.x","volume":"101","author":"E Gouzoulis-Mayfrank","year":"2006","unstructured":"Gouzoulis-Mayfrank E, Daumann J (2006b) Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage? Addiction 101:348\u2013361","journal-title":"Addiction"},{"key":"3722_CR22","doi-asserted-by":"crossref","first-page":"305","DOI":"10.31887\/DCNS.2009.11.3\/egmayfrank","volume":"11","author":"E Gouzoulis-Mayfrank","year":"2009","unstructured":"Gouzoulis-Mayfrank E, Daumann J (2009) Neurotoxicity of drugs of abuse\u2013the case of methylenedioxyamphetamines (MDMA, ecstasy), and amphetamines. Dialogues Clin Neurosci 11:305\u2013317","journal-title":"Dialogues Clin Neurosci"},{"key":"3722_CR23","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/10550490050172209","volume":"9","author":"D Harris","year":"2000","unstructured":"Harris D, Batki SL (2000) Stimulant psychosis: symptom profile and acute clinical course. Am J Addict 9:28\u201337","journal-title":"Am J Addict"},{"key":"3722_CR24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF00491982","volume":"65","author":"DS Janowsky","year":"1979","unstructured":"Janowsky DS, Risch C (1979) Amphetamine psychosis and psychotic symptoms. Psychopharmacology (Berl) 65:73\u201377","journal-title":"Psychopharmacology (Berl)"},{"key":"3722_CR25","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.neuroscience.2012.06.049","volume":"221","author":"P Koester","year":"2012","unstructured":"Koester P, Tittgemeyer M, Wagner D, Becker B, Gouzoulis-Mayfrank E, Daumann J (2012) Cortical thinning in amphetamine-type stimulant users. Neuroscience 221:182\u2013192","journal-title":"Neuroscience"},{"key":"3722_CR26","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0376-8716(02)00190-4","volume":"68","author":"R Lieb","year":"2002","unstructured":"Lieb R, Schuetz CG, Pfister H, von Sydow K, Wittchen H (2002) Mental disorders in ecstasy users: a prospective-longitudinal investigation. Drug Alcohol Depend 68:195\u2013207","journal-title":"Drug Alcohol Depend"},{"key":"3722_CR27","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/j.1360-0443.2010.02932.x","volume":"105","author":"BD Marshall","year":"2010","unstructured":"Marshall BD, Werb D (2010) Health outcomes associated with methamphetamine use among young people: a systematic review. Addiction 105:991\u20131002","journal-title":"Addiction"},{"key":"3722_CR28","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.drugalcdep.2006.09.003","volume":"87","author":"KL Medina","year":"2007","unstructured":"Medina KL, Shear PK (2007) Anxiety, depression, and behavioral symptoms of executive dysfunction in ecstasy users: contributions of polydrug use. Drug Alcohol Depend 87:303\u2013311","journal-title":"Drug Alcohol Depend"},{"key":"3722_CR29","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s002130100907","volume":"159","author":"MJ Morgan","year":"2002","unstructured":"Morgan MJ, McFie L, Fleetwood H, Robinson JA (2002) Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence? Psychopharmacology (Berl) 159:294\u2013303","journal-title":"Psychopharmacology (Berl)"},{"key":"3722_CR30","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1080\/20786204.2006.10873344","volume":"48","author":"B Myers","year":"2006","unstructured":"Myers B, Parry CD, Karasellos C, Jardine G (2006) Methamphetamine abuse, psychosis and your patient : review article. South Afr Fam Pract 48:56\u201357","journal-title":"South Afr Fam Pract"},{"key":"3722_CR31","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0091-3057(01)00711-0","volume":"71","author":"AC Parrott","year":"2002","unstructured":"Parrott AC (2002) Recreational Ecstasy\/MDMA, the serotonin syndrome, and serotonergic neurotoxicity. Pharmacol Biochem Behav 71:837\u2013844","journal-title":"Pharmacol Biochem Behav"},{"key":"3722_CR32","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s00702-007-0715-7","volume":"114","author":"AC Parrott","year":"2007","unstructured":"Parrott AC, Milani RM, Gouzoulis-Mayfrank E, Daumann J (2007) Cannabis and ecstasy\/MDMA (3,4-methylenedioxymethamphetamine): an analysis of their neuropsychobiological interactions in recreational users. J Neural Transm 114:959\u2013968","journal-title":"J Neural Transm"},{"key":"3722_CR33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s002130100897","volume":"159","author":"AC Parrott","year":"2001","unstructured":"Parrott AC, Milani RM, Parmar R, Turner JD (2001) Recreational ecstasy\/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems. Psychopharmacology (Berl) 159:77\u201382","journal-title":"Psychopharmacology (Berl)"},{"key":"3722_CR34","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1600-0447.2004.00321.x","volume":"110","author":"G Pedersen","year":"2004","unstructured":"Pedersen G, Karterud S (2004) Is SCL-90R helpful for the clinician in assessing DSM-IV symptom disorders? Acta Psychiatr Scand 110:215\u2013224","journal-title":"Acta Psychiatr Scand"},{"key":"3722_CR35","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/hup.350","volume":"16","author":"K Soar","year":"2001","unstructured":"Soar K, Turner JJ, Parrott AC (2001) Psychiatric disorders in Ecstasy (MDMA) users: a literature review focusing on personal predisposition and drug history. Hum Psychopharmacol 16:641\u2013645","journal-title":"Hum Psychopharmacol"},{"key":"3722_CR36","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1177\/0269881106063274","volume":"20","author":"K Soar","year":"2006","unstructured":"Soar K, Turner JJ, Parrott AC (2006) Problematic versus non-problematic ecstasy\/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors. J Psychopharmacol 20:417\u2013424","journal-title":"J Psychopharmacol"},{"key":"3722_CR37","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.addbeh.2005.10.004","volume":"31","author":"I Sommers","year":"2006","unstructured":"Sommers I, Baskin D, Baskin-Sommers A (2006) Methamphetamine use among young adults: health and social consequences. Addict Behav 31:1469\u20131476","journal-title":"Addict Behav"},{"key":"3722_CR38","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/0269881104040239","volume":"18","author":"HR Sumnall","year":"2004","unstructured":"Sumnall HR, Wagstaff GF, Cole JC (2004) Self-reported psychopathology in polydrug users. J Psychopharmacol 18:75\u201382","journal-title":"J Psychopharmacol"},{"key":"3722_CR39","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.drugalcdep.2008.11.014","volume":"101","author":"CG Sutcliffe","year":"2009","unstructured":"Sutcliffe CG, German D, Sirirojn B, Latkin C, Aramrattana A, Sherman SG, Celentano DD (2009) Patterns of methamphetamine use and symptoms of depression among young adults in northern Thailand. Drug Alcohol Depend 101:146\u2013151","journal-title":"Drug Alcohol Depend"},{"key":"3722_CR40","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00213-013-3288-1","volume":"231","author":"L Taurah","year":"2014","unstructured":"Taurah L, Chandler C, Sanders G (2014) Depression, impulsiveness, sleep, and memory in past and present polydrug users of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy). Psychopharmacology (Berl) 231:737\u2013751","journal-title":"Psychopharmacology (Berl)"},{"key":"3722_CR41","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00213-002-1383-9","volume":"167","author":"R Thomasius","year":"2003","unstructured":"Thomasius R, Petersen K, Buchert R, Andresen B, Zapletalova P, Wartberg L, Nebeling B, Schmoldt A (2003) Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users. Psychopharmacology (Berl) 167:85\u201396","journal-title":"Psychopharmacology (Berl)"},{"key":"3722_CR42","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/0269881106059486","volume":"20","author":"R Thomasius","year":"2006","unstructured":"Thomasius R, Zapletalova P, Petersen K, Buchert R, Andresen B, Wartberg L, Nebeling B, Schmoldt A (2006) Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective. J Psychopharmacol 20:211\u2013225","journal-title":"J Psychopharmacol"},{"key":"3722_CR43","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1037\/0022-0167.44.3.294","volume":"44","author":"DM Todd","year":"1997","unstructured":"Todd DM, Deane FP, McKenna PA (1997) Appropriateness of SCL-90-R adolescent and adult norms for outpatient and nonpatient college students. J Couns Psychol 44:294\u2013301","journal-title":"J Couns Psychol"},{"key":"3722_CR44","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000050709","volume":"7","author":"P Tossmann","year":"2001","unstructured":"Tossmann P, Boldt S, Tensil MD (2001) The use of drugs within the techno party scene in European metropolitan cities. Eur Addict Res 7:2\u201323","journal-title":"Eur Addict Res"},{"key":"3722_CR45","doi-asserted-by":"crossref","unstructured":"Turner JJ1, Parrott AC, Goodwin J, Moore DG, Fulton S, Min MO, Singer LT (2014) Psychiatric profiles of mothers who take Ecstasy\/MDMA during pregnancy: reduced depression 1 year after giving birth and quitting Ecstasy. J Psychopharmacol 28(1):55\u201361. doi: 10.1177\/0269881113515061","DOI":"10.1177\/0269881113515061"},{"key":"3722_CR46","unstructured":"UNODC (2012) World Drug Report 2012. United Nations Publication, Vienna"},{"key":"3722_CR47","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/hup.529","volume":"18","author":"SL Verheyden","year":"2003","unstructured":"Verheyden SL, Henry JA, Curran HV (2003a) Acute, sub-acute and long-term subjective consequences of \u2018ecstasy\u2019 (MDMA) consumption in 430 regular users. Hum Psychopharmacol 18:507\u2013517","journal-title":"Hum Psychopharmacol"},{"key":"3722_CR48","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/0269881103174014","volume":"17","author":"SL Verheyden","year":"2003","unstructured":"Verheyden SL, Maidment R, Curran HV (2003b) Quitting ecstasy: an investigation of why people stop taking the drug and their subsequent mental health. J Psychopharmacol 17:371\u2013378","journal-title":"J Psychopharmacol"},{"key":"3722_CR49","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0376-8716(01)00195-8","volume":"66","author":"K Sydow von","year":"2002","unstructured":"von Sydow K, Lieb R, Pfister H, Hofler M, Wittchen HU (2002) Use, abuse and dependence of ecstasy and related drugs in adolescents and young adults - a transient phenomenon? Results from a longitudinal community study. Drug Alcohol Depend 66:147\u2013159","journal-title":"Drug Alcohol Depend"},{"key":"3722_CR50","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.pnpbp.2010.04.004","volume":"34","author":"D Wagner","year":"2010","unstructured":"Wagner D, Becker B, Gouzoulis-Mayfrank E, Daumann J (2010) Interactions between specific parameters of cannabis use and verbal memory. Prog Neuropsychopharmacol Biol Psychiatry 34:871\u2013876","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3722_CR51","doi-asserted-by":"crossref","unstructured":"Wagner D, Becker B, Koester P, Gouzoulis-Mayfrank E, Daumann J (2012) A prospective study of learning, memory, and executive function in new MDMA users. Addiction","DOI":"10.1111\/j.1360-0443.2012.03977.x"},{"key":"3722_CR52","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1176\/appi.ajp.161.2.242","volume":"161","author":"GJ Wang","year":"2004","unstructured":"Wang GJ, Volkow ND, Chang L, Miller E, Sedler M, Hitzemann R, Zhu W, Logan J, Ma Y, Fowler JS (2004) Partial recovery of brain metabolism in methamphetamine abusers after protracted abstinence. Am J Psychiatry 161:242\u2013248","journal-title":"Am J Psychiatry"},{"key":"3722_CR53","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.addbeh.2009.03.029","volume":"34","author":"LT Wu","year":"2009","unstructured":"Wu LT, Parrott AC, Ringwalt CL, Patkar AA, Mannelli P, Blazer DG (2009) The high prevalence of substance use disorders among recent MDMA users compared with other drug users: Implications for intervention. Addict Behav 34:654\u2013661","journal-title":"Addict Behav"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-014-3722-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-014-3722-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-014-3722-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T14:42:01Z","timestamp":1650033721000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-014-3722-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,27]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["3722"],"URL":"https:\/\/doi.org\/10.1007\/s00213-014-3722-z","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,27]]}}}